grinboss

Cooper Companies

COO

What is it worth to you? Move six assumptions and see what value per share you get, and where you stand against the price and other users.

At $60.75 (close on November 18) and with the other assumptions at their starting point, Cooper Companies's sales would need to grow 13.5% a year for ten years; over its last decade, the median was 8.7%. Value it with your own assumptions.

Its accounts, year by year

Year endSalesGrowthMargin
10/20151,797—15.0%
10/20161,9679.4%18.0%
10/20172,1398.8%21.8%
10/20182,53318.4%17.6%
10/20192,6534.8%21.9%
10/20202,431−8.4%14.4%
10/20212,92220.2%18.8%
10/20223,30813.2%17.0%
10/20233,5938.6%16.6%
10/20243,8958.4%20.0%
10/20254,0925.1%18.4%

Sales in millions of dollars. The margin is the operating margin before stock pay, as a percentage of sales. Each row is a fiscal year, by the month it ends. Source: the reports Cooper Companies files with the SEC, the US securities regulator; the latest is for the fiscal year ended October 31, 2025. See the report.

The model's starting point

  • Sales growth, years 1 to 10: 8.6% a year.
  • Sales growth after year 10: 2.5% a year.
  • Operating margin, before stock pay: 18.4% of sales.
  • Working capital needed to grow: $22.7 per $100 of new sales.
  • Capital spending: 8.9% of sales.
  • Stock pay to employees: 2.3% of sales.
  • Discount rate, the same for every company: 10%.

These are the six assumptions the page starts with; each user moves them as they see fit.

Reference points

They come from its accounts and its share price, compared with the median of the companies on grinboss. They are not a recommendation.

For

  • It sold more than the year before in 9 of the last 10 years.
  • It generated free cash flow in each of the last 5 years.
  • Its sales grew 8.6% a year on average over 10 years, from $1.8 billion to $4.1 billion; the median of grinboss companies is 6.6%.
  • Over ten years, its worst fall from a high was 53%; the median is 56%.

Against

  • It ties up $23 in inventory and unpaid customer bills for every $100 of new sales, more than the median ($2).
  • It is one of the smallest in grinboss: it sells $4.1 billion a year; the median is $15.1 billion.
  • It needs to invest a lot: its capital spending takes 8.9% of its sales every year, more than the median (3.3%).
  • Its net debt equals 2.2 years of operating profit plus depreciation and amortization (EBITDA), more than the median (1.5).

Next results: December 3, 2026.

Other companies in its sector (Health Care)

Cencora (COR) · Charles River Laboratories (CRL) · CVS Health (CVS) · Quest Diagnostics (DGX) · Danaher Corporation (DHR) · DaVita (DVA) · Dexcom (DXCM) · Edwards Lifesciences (EW) · All companies

Loading the model…